Life Sciences
6 stories covering life sciences — fund closes, LP allocations, regulatory filings, deal flow, and fundraising signals from PipelineRoad's editorial team.
Canton Strategic Holdings Files Form D with SEC
Canton Strategic Holdings, Inc. submitted a Form D filing to the SEC on April 15, 2026, for an exempt securities offering in the pharmaceutical sector.
Petrichor Appoints Paul J. Sekhri as Operating Partner
Petrichor, a growth-focused healthcare and life sciences investment firm, has appointed Paul J. Sekhri as Operating Partner, drawing on his over 35 years of experience in biotech and pharmaceuticals.
Investors Back Kailera with $1 Billion Amid IPO Hopes
Atlas Venture, Bain Capital, and others have invested $1 billion in Kailera, a company producing weight-loss injectables, as it eyes an IPO in a challenging market.
Investors Back Kailera with $1bn for Weight-Loss Injectables Ahead of IPO
Atlas Venture, Bain Capital, and other investors have committed $1bn to Kailera, a company producing weight-loss injectables, as it prepares for an IPO in a challenging market.
Blackstone Leads $1.3bn Financing for Paratek-Radius Merger
Blackstone Inc heads a $1.3bn private funding package for the merger of Paratek Pharmaceuticals and Radius Health, involving key lenders like Sixth Street Partners.
KALA BIO Announces AI Platform for Biotech and Pharma Sector
KALA BIO enters agreement with Younet AI to develop an on-premises AI infrastructure for secure biotech data analysis, addressing industry challenges.
